These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 34560157)

  • 1. Enhanced topical corticosteroids delivery to the eye: A trade-off in strategy choice.
    Shen L; Fang G; Tang B; Zhu Q
    J Control Release; 2021 Nov; 339():91-113. PubMed ID: 34560157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving corneal permeability of dexamethasone using penetration enhancing agents: First step towards achieving topical drug delivery to the retina.
    Thareja A; Leigh T; Hakkarainen JJ; Hughes H; Alvarez-Lorenzo C; Fernandez-Trillo F; Blanch RJ; Ahmed Z
    Int J Pharm; 2024 Jul; 660():124305. PubMed ID: 38852749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery.
    Jiao J
    Adv Drug Deliv Rev; 2008 Dec; 60(15):1663-73. PubMed ID: 18845195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug Delivery for Ocular Allergy: Current Formulation Design Strategies and Future Perspectives.
    Regu VR; Swain RP; Subudhi BB
    Curr Pharm Des; 2023; 29(33):2626-2639. PubMed ID: 37936454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability and anticataract effects of a topical ocular drug delivery system containing disulfiram and hydroxypropyl-beta-cyclodextrin on selenite-treated rats.
    Wang S; Li D; Ito Y; Nabekura T; Wang S; Zhang J; Wu C
    Curr Eye Res; 2004 Jul; 29(1):51-8. PubMed ID: 15370367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Advances in Topical Ocular Drug Delivery.
    Yellepeddi VK; Palakurthi S
    J Ocul Pharmacol Ther; 2016 Mar; 32(2):67-82. PubMed ID: 26666398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colloidal nanosystems with mucoadhesive properties designed for ocular topical delivery.
    Silva B; São Braz B; Delgado E; Gonçalves L
    Int J Pharm; 2021 Sep; 606():120873. PubMed ID: 34246741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fabrication of a drug delivery system that enhances antifungal drug corneal penetration.
    Li J; Li Z; Liang Z; Han L; Feng H; He S; Zhang J
    Drug Deliv; 2018 Nov; 25(1):938-949. PubMed ID: 29658325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular preparations: the formulation approach.
    Kaur IP; Kanwar M
    Drug Dev Ind Pharm; 2002 May; 28(5):473-93. PubMed ID: 12098838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patent perspectives for corticosteroids based ophthalmic therapeutics.
    Suresh PK; Sah AK
    Recent Pat Drug Deliv Formul; 2014; 8(3):206-23. PubMed ID: 25020063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular delivery systems for topical application of anti-infective agents.
    Duxfield L; Sultana R; Wang R; Englebretsen V; Deo S; Rupenthal ID; Al-Kassas R
    Drug Dev Ind Pharm; 2016 Jan; 42(1):1-11. PubMed ID: 26325119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic nanoemulsions in ophthalmic drug administration: Concept in formulations and characterization techniques for ocular drug delivery.
    Singh M; Bharadwaj S; Lee KE; Kang SG
    J Control Release; 2020 Dec; 328():895-916. PubMed ID: 33069743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Locally administered ocular corticosteroids: benefits and risks.
    McGhee CN; Dean S; Danesh-Meyer H
    Drug Saf; 2002; 25(1):33-55. PubMed ID: 11820911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug delivery to the anterior segment of the eye: A review of current and future treatment strategies.
    Mofidfar M; Abdi B; Ahadian S; Mostafavi E; Desai TA; Abbasi F; Sun Y; Manche EE; Ta CN; Flowers CW
    Int J Pharm; 2021 Sep; 607():120924. PubMed ID: 34324989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent updates on ocular disease management with ophthalmic ointments.
    Bisen AC; Dubey A; Agrawal S; Biswas A; Rawat KS; Srivastava S; Bhatta RS
    Ther Deliv; 2024; 15(6):463-480. PubMed ID: 38888757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular Drug Delivery: a Comprehensive Review.
    Ahmed S; Amin MM; Sayed S
    AAPS PharmSciTech; 2023 Feb; 24(2):66. PubMed ID: 36788150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives.
    Gaballa SA; Kompella UB; Elgarhy O; Alqahtani AM; Pierscionek B; Alany RG; Abdelkader H
    Drug Deliv Transl Res; 2021 Jun; 11(3):866-893. PubMed ID: 32901367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of Approaches for Increasing Ophthalmic Bioavailability for Eye Drop Formulations.
    Lanier OL; Manfre MG; Bailey C; Liu Z; Sparks Z; Kulkarni S; Chauhan A
    AAPS PharmSciTech; 2021 Mar; 22(3):107. PubMed ID: 33719019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioactivation antioxidant and transglycating properties of N-acetylcarnosine autoinduction prodrug of a dipeptide L-carnosine in mucoadhesive drug delivery eye-drop formulation: powerful eye health application technique and therapeutic platform.
    Babizhayev MA
    Drug Test Anal; 2012 Jun; 4(6):468-85. PubMed ID: 21416634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penetration enhancers and ocular bioadhesives: two new avenues for ophthalmic drug delivery.
    Kaur IP; Smitha R
    Drug Dev Ind Pharm; 2002 Apr; 28(4):353-69. PubMed ID: 12056529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.